Clinical Trials Directory

Trials / Completed

CompletedNCT03249974

Comparison Between Enlite and Flash Glucose Monitoring

A Comparative Study on the Accuracy, Ease of Use and Skin Reactions Between the Enlite Sensor With Guardian 2 Link Transmitter and the FreeStyle Libre Flash Glucose Sensor

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Jessa Hospital · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

1. The accuracy of the sensors (Flash vs Enlite glucose monitoring) will be evaluated with a standardized breakfast test. Patients receive a standardized breakfast. The usual insulin bolus will be administered at breakfast. After breakfast, a venous blood sample is taken for 2 hours every 15 minutes to determine the blood sugar. At the same time, the glucose value shown by the sensors will be noted. A comparison of the blood glucose value with the data recorded by the sensor can evaluate the accuracy of the sensor and also estimate the lag-time between the sensor glucose and the venous glucose. 2. Patient satisfaction will be evaluated using a questionnaire that will be completed after the Enlite sensor has been worn for 1 month. 3. The development of skin reactions will be checked by a short questionnaire, supplemented with a picture of possible skin phenomena. 4. The data recorded by the FreeStyle sensor (average glucose,% above target,% within target,% under target, amount of hypoglycemia) in the month prior to sensor switching will be compared to the same data recorded by the Enlite sensor during the first month of use.

Conditions

Interventions

TypeNameDescription
DEVICEEnlite sensor communicating with Minimed 640G pumpChildren (5 to 18 years) with type 1 diabetes mellitus treated with an insulin pump and wearing a FreeStyle Flash Libre glucosesensor will switch to the Enlite sensor communicating with Minimed 640G pump

Timeline

Start date
2017-07-05
Primary completion
2018-07-04
Completion
2018-07-04
First posted
2017-08-15
Last updated
2018-07-11

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03249974. Inclusion in this directory is not an endorsement.